Continuing Education

Advancements in Metastatic Triple-Negative Breast Cancer: Treatment Discussions and Managed Care Considerations

Expiration Date: May 19th, 2021

This activity will explain the pathophysiology, prognosis, and challenges of treating metastatic triple-negative breast cancer.

Parkinson Disease: A Review of Treatment Guidelines, Healthcare Utilization Data, and Emerging Therapies

Expiration Date: November 18th, 2021

This activity will provide a review of the current treatment landscape of PD and an in-depth overview of emerging disease-modifying therapies under development.

Assessing Advancements in Early Cancer Detection: A Managed Care Review of New Diagnostics to Improve Outcomes

Expiration Date: November 16th, 2021

This activity will provide managed care professionals with an overview of trial data related to screening tests under development with a discussion of the potential impact if such technologies are incorporated into screening.

Preventing Medication Errors: A Practical Guide for Pharmacists

Expiration Date: November 8th, 2021

This activity will empower pharmacists to identify potential areas in which medication errors can occur and develop strategies to better prevent them to ensure patient safety.

The Pharmacoeconomic Burden of Insomnia: Current Treatment Challenges and Updates on Safe and Efficacious Options

Expiration Date: November 3rd, 2021

The up-to-date information explored in this program will help managed care professionals incorporate cost-effective pharmaceutical care and protocols into practice to provide high-quality care to patients with insomnia.

Parkinson Disease: A Review of Guidelines, Updates, and Treatment Advances

Expiration Date: October 30th, 2021

This activity will review ongoing clinical trial data for agents targeting the α-synuclein pathology associated with Parkinson disease as well as new formulations with the potential to minimize motor-related complications.

The Evolving Strategies in HIV Management and Clinical Updates on Injectable and Implantable Therapies

Expiration Date: October 30th, 2021

This activity will articulate the economic and health-related value of preventing infection and maintaining HIV viral load suppression.

Beta Thalassemia: Healthcare Utilization and Managed Care Implications

Expiration Date: October 30th, 2021

This activity will examine the pathophysiology of β thalassemia and associated complications.

Addressing Clinical and Economic Burden in Alzheimer Disease: Examining New and Emerging Therapies and Optimizing Patient Care, an AMCP Nexus Satellite Symposium, featuring a Caregiver Perspective

Expiration Date: October 30th, 2021

This activity will detail the role of the pharmacist in collaboration with managed care professionals and clinicians to promote drug utilization strategies that can be initiated early in the treatment course of AD.

Access to Early and Effective Treatment in Sickle Cell Disease: The Role of New Therapies to Meet Unmet Needs in Care

Expiration Date: October 30th, 2021

This activity will further explore their important roles in the management of patients with SCD from determining appropriate use of newly approved treatments to ensuring adherence and recommending dose adjustments that limit disease progression and associated complications to optimize cost-effective treatment for patients with SCD.

Real-World Data on Neovascular Age-Related Macular Degeneration: Preserving Vision Acuity While Decreasing Injection Burden of Anti-VEGF Treatments

Expiration Date: October 27th, 2021

This activity will focus on the appropriate consideration of emerging therapies to treat neovascular AMD, factors that contribute to decreasing the disease burden, and use of best practices in cost management.

Spinal Muscular Atrophy: Updates in Clinical Trial Data and What Managed Care Professionals Need to Know, featuring a Patient Perspective

Expiration Date: October 27th, 2021

This activity will characterize the pathogenesis of spinal muscular atrophy (SMA) including its clinical presentation, classifications, diagnosis, and the need for early intervention.

Advances in Early Cancer Detection: Insights for Managed Care Professionals

Expiration Date: October 28th, 2021

This activity will provide managed care professionals with an overview of trial data related to multicancer screening tests under development and discuss important considerations when incorporating such technologies into screening policies and procedures.

Adopting Oncology Biosimilars Into Clinical Practice: How Pharmacists Can Help Pave the Way

Expiration Date: April 23rd, 2021

This activity will apply knowledge of the challenges associated with the adoption of biosimilars into clinical practice to a real-world patient and clinician counseling scenario.

Managed Care Considerations for Chronic Cough

Expiration Date: October 15th, 2021

This 3-part supplement will explain the treatment options for chronic cough including the emerging therapies.

Secondary Progressive Multiple Sclerosis: Effective Management Strategies for Pharmacists

Expiration Date: October 14th, 2021

This activity will express the etiology, pathophysiology, classification, and diagnosis of secondary progressive multiple sclerosis (SPMS)

Hepatocellular Carcinoma: Examining the Latest Evidence for Managed Care

Expiration Date: April 7th, 2021

This supplement was developed with the goal of providing pharmacists and managed care professionals with an understanding of current treatment options for HCC, with a focus on assisting managed care professionals in optimizing patient outcomes.

Biosimilars: A Managed Care Update of Real-World Evidence and Cost-Savings Data When Treating Inflammatory Conditions

Expiration Date: October 9th, 2021

This activity will identify the patient populations with rheumatic and inflammatory disease and consider the biologic costs associated with pharmacologic treatment.

Current and Emerging Treatment Options for Chronic Cough: The Role of Managed Care

Expiration Date: October 2nd, 2021

This activity will construct a treatment plan for patients with chronic cough that targets the type of cough and minimizes adverse effects.

Ankylosing Spondylitis: Targeting Interleukin Pathways for Early and Aggressive Disease Management

Expiration Date: October 2nd, 2021

This activity will explore the role of the interleukin pathway in ankylosing spondylitis (AS) and the need for early and aggressive disease management.

Understanding the Treatment Paradigm for Idiopathic Pulmonary Fibrosis: A Guide for the Specialty Pharmacist

Expiration Date: October 2nd, 2021

This activity will review additional actions the specialty pharmacist can take to contribute to the care of patients with IPF.

Hemophilia and Inhibitors: Prevention and Management Updates for the Specialty Pharmacist

Expiration Date: October 2nd, 2021

This activity will examine the burden of inhibitor development on the treatment and clinical outcomes of patients with hemophilia.

Multiple Myeloma: Assessing Current Trends and Payer Strategies for Managing Costs

Expiration Date: March 30th, 2021

Throughout this discussion, a diverse faculty panel of oncology and managed care experts will address changes to treatment approaches and present methods to overcoming challenges associated with treatment resistance and adherence barriers while maintaining control over costs.

Immunoglobulin Use in Chronic Inflammatory Demyelinating Polyneuropathy: A Discussion of Treatment and Management

Expiration Date: September 30th, 2021

The different perspectives of the panelists in this discussion and accompanying device demonstration videos will equip managed care pharmacists with strategies to standardize management, decrease healthcare utilization and treatment burden, and optimize outcomes of patients with CIDP.